Pacira Pharmaceuticals Inc (NASDAQ:PCRX)
| 29.74 Data as of 2:37pm ET |  +0.66 / +2.25%Today’s Change | 9.90 Today|||52-Week Range 30.94 | +70.21% Year-to-Date |
Latest PCRX News | Press Releases
| Pacira Reports Wider Loss - Analyst Blog May 10 / Zacks.com |
Today’s Trading
| Previous close | 29.08 |
| Today’s open | 28.67 |
| Day’s range | 28.60 - 29.90 |
| Volume | 166,433 |
| Average volume (3 months) | 497,115 |
| Market cap | $961.0M |
| Dividend yield | -- |
Data as of 2:37pm ET, 05/23/2013
Growth & Valuation
| Earnings growth (last year) | +34.85% |
| Earnings growth (this year) | +1.16% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +149.12% |
| P/E ratio | NM |
| Price/Sales | 13.56 |
| Price/Book | 14.41 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| CMNCantel Medical Corp | -0.20 | -0.57% |
| CNMDConmed Corp | +0.19 | +0.57% |
| SPNCSpectranetics Corp | +0.10 | +0.53% |
| MDXGMiMedx Group Inc | -0.27 | -3.66% |
Data as of 2:52pm ET, 05/23/2013
Financials
| Next reporting date | August 15, 2013 |
| EPS forecast (this quarter) | -$0.43 |
| Annual revenue (last year) | $39.1M |
| Annual profit (last year) | -$52.3M |
| Net profit margin | -133.77% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
President, Chief Executive Officer & Director David M. Stack |
CFO, Head-Investor & Media Relations James S. Scibetta, MBA |
Corporate headquarters Parsippany, New Jersey |
Forecasts
